Studer, V., Ferri, A., Perugini, J., Clerici, V., Confalonieri, P., Antozzi, C., et al. (2019). Influence of Alemtuzumab Treatment on Peripheral Mediators of Inflammation in Relapsing-Remitting Multiple Sclerosis Patients. Intervento presentato a: 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) - October 10 - 12, 2018, Berlin, Germany.

Influence of Alemtuzumab Treatment on Peripheral Mediators of Inflammation in Relapsing-Remitting Multiple Sclerosis Patients

Perugini, Jacopo;Schilke, Edoardo;Brambilla, Laura
2019

abstract + poster
multiple sclerosis; alemtuzumab; cardiac side effect; cytokines
English
34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) - October 10 - 12, 2018
2018
2019
none
Studer, V., Ferri, A., Perugini, J., Clerici, V., Confalonieri, P., Antozzi, C., et al. (2019). Influence of Alemtuzumab Treatment on Peripheral Mediators of Inflammation in Relapsing-Remitting Multiple Sclerosis Patients. Intervento presentato a: 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) - October 10 - 12, 2018, Berlin, Germany.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/615761
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact